70
Participants
Start Date
September 30, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
CD07805/47 gel 0.5%/CD07805/47 Vehicle
"To maintain masking, CD07805/47 gel 0.5% will be administered along with CD07805/47 gel vehicle.~During each treatment period (baseline to Day 15):~CD07805/47 gel 0.5%, topical, once daily and CD07805/47 gel vehicle, topical, once daily"
azelaic acid gel 15%
During each treatment period (baseline to Day 15): azelaic acid gel 15%, topical, twice daily
The Education & Research Foundation, Inc., Lynchburg
Dermatology Specialists Research, LLC, Louisville
Hudson Dermatology, Evansville
DermResearch, Inc, Austin
Lead Sponsor
Galderma R&D
INDUSTRY